Physician profile
Christopher Robert Wild
NPI 1356696595
$4,834.42
in general payments reported to CMS, 2019-2025
16 companies · $611 in 2025
The $611 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $104 · 2021: $147 · 2022: $148 · 2023: $1,178 · 2024: $2,515 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,309 · Travel and Lodging: $1,844 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,309.41 |
| Travel and Lodging | $1,844.24 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,255.35 | 2024-2025 | Avenir, Persona, Gel-One Cross-Linked Hyaluronate |
| Arthrex, INC. | $792.16 | 2023 | |
| Stryker Corporation | $455.27 | 2021-2025 | Aequalis Perform Reversed, Gmrs, Tornier Flex |
| Pylant Medical | $351.02 | 2023-2025 | |
| Depuy Synthes Sales INC. | $324.52 | 2022-2025 | Na, Lcp, Va-Lcp |
| P Bar Medical LLC | $157.12 | 2025 | |
| Smith+Nephew, INC. | $117.40 | 2019-2022 | |
| Wright Medical Technology, INC. | $104.21 | 2020 | |
| Bioventus LLC | $100.19 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Relievant Medsystems, INC. | $38.69 | 2019 | |
| Ferring Pharmaceuticals INC. | $37.60 | 2025 | Euflexxa |
| Orthalign INC | $25.90 | 2023 | Orthalign Plus |
| Sanofi-Aventis U.S. LLC | $24.91 | 2019 | |
| Vericel Corporation | $21.98 | 2023 | Maci |
| Kowa Pharmaceuticals America, INC. | $16.34 | 2023 | Seglentis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.